About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Repeated High-dose Inhaled Corticosteroids for Asthma

NCT00695604·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Chicago

Age

18–50

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Physician diagnosis of asthma.
Age ≥18 years and ≤50 years
Evidence of airflow obstruction as measured by spirometry and flow-volume loop per American Thoracic Society guidelines.
Treatment for asthma with:
* daily inhaled corticosteroids and long-acting beta2-agonists, AND
* as-needed use of a short-acting beta2-agonist

You may not be if

History of \>10 pack-year tobacco use
Other pulmonary or cardiac diagnosis that is actively being treated
History of adverse events or allergy to fluticasone
Systemic corticosteroid therapy within 7 days of study visit
Inability to obtain written informed consent

The record

StatusWithdrawn

PhasePhase 2

Taking part0

StartedMay 2008

UpdatedMay 8, 2018

Conditions

Where1

The University of Chicago
Chicago, Illinois, United States

Clareo Health | Repeated High-dose Inhaled Corticosteroids for Asthma